Population-based impact of routine infant immunization with pneumococcal conjugate vaccine in the USA

作者：Carlos Gabriel Grijalva, Marie R. Griffin · 发表于：Expert Review of Vaccines · 年份：2008 · DOI：10.1586/14760584.7.1.83 · 被引用次数：63 · 研究领域：Pneumonia and Respiratory Infections、Respiratory viral infections research、Bacterial Infections and Vaccines

In the year 2000, a heptavalent pneumococcal conjugate vaccine (PCV7) was licensed and recommended for routine immunization of infants in the USA. During the following years, a number of studies documented the impact of this immunization program on rates of invasive pneumococcal disease, pneumonia and otitis media. This article aims to summarize current evidence on the population-based impact of this infant immunization program in the USA.